Related Experiment Video
Updated: Jun 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pediatric disease burden and vaccination recommendations: understanding local differences
Angela Gentile1, Zulfiqar Bhutta, Lulu Bravo
1Ricardo Guiterrez Children's Hospital, Gallo Buenos Aires, Argentina. angelagentile@fibertel.com.ar
Insights
Vaccination coverage for diseases like diphtheria, tetanus, and pertussis varies globally. Combination vaccines (DTwP-HepB-Hib) offer a cost-effective way to improve coverage and reduce disease burden.
Area of Science:
- Public Health
- Vaccinology
- Epidemiology
Background:
- Diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, and measles cause significant global health issues.
- These vaccine-preventable diseases contribute to substantial worldwide morbidity and mortality.
Purpose of the Study:
- To review geographic variations in disease burden for D, T, P, HepB, and Hib.
- To analyze vaccination coverage and recommendations across different World Health Organization (WHO) regions.
- To illustrate these differences using country-specific examples.
Main Methods:
- Comparative analysis of disease incidence and vaccination coverage data.
- Review of national vaccination schedules and recommendations.
- Geographic comparison across African, Americas, Mediterranean, South-East Asian, and Western Pacific WHO regions.
Main Results:
- Significant disparities in disease incidence and vaccination coverage were observed between countries.
- Low vaccination coverage for Hepatitis B and invasive Hib disease was noted in several WHO regions, particularly in Africa and South-East Asia.
- Some countries' vaccination schedules lacked or recently introduced HepB and Hib vaccines; DTwP-HepB-Hib combination vaccines are increasingly adopted.
Conclusions:
- Vaccination coverage and schedules differ significantly across countries, often influenced by available resources.
- DTwP-HepB-Hib combination vaccines are a cost-effective strategy to enhance vaccination coverage and compliance.
- These combination vaccines hold potential for substantially reducing the burden of these serious diseases.
Background:
Diphtheria (D), tetanus (T), pertussis (P), hepatitis B (HepB), invasive Haemophilus influenzae type b (Hib) disease, and measles cause substantial global morbidity and mortality.
Methods:
This unique review highlights geographic differences in disease burden across certain countries in the African, Americas, Mediterranean, South-East Asian, and Western Pacific World Health Organization (WHO) regions, and relates this to vaccination coverage and local vaccine recommendations using the authors' countries as illustrations.
Results:
Substantial differences were observed in the incidence of these diseases and in vaccination coverage between the countries studied. Disease incidence often reflected inadequate surveillance, but also variable or poor vaccination coverage. Vaccination coverage against HepB was particularly low in the African and South-East Asian WHO regions; vaccination coverage against invasive Hib disease was low in these regions and in the Eastern Mediterranean and Western Pacific WHO regions. Vaccination schedules within some countries in these regions do not include, or have only recently included, vaccinations against HepB and Hib disease. The use of DTwP-HepB-Hib (diphtheria, tetanus, whole-cell pertussis, HepB, Hib) combination vaccines has now been adopted by some countries to help increase vaccination coverage.
Conclusions:
Vaccination coverage and vaccination schedules vary markedly between the countries studied, often according to the resources available. DTwP-HepB-Hib combination vaccines represent a cost-effective option, with the potential to substantially reduce the burden associated with these diseases by increasing coverage and compliance.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Vaccinations
Smallpox
